|
Upon receipt at our post market quality assurance laboratory, additional information from product investigation indicates that the device was not returned for analysis; therefore, a technical analysis could not be performed.Good faith effort attempts were made to try and retrieve the device; however, response was not received.A risk review was not required.Furthermore, the event was not reportable in an eea or great britain country, then bsc was not responsible for training with no new hazard was identified.An effective ifu version was not available for this product because the product was no longer manufactured.Consequently, a labeling review was not conducted, as the manual cannot be revised for translation, wording, or graphics.A similar complaint review was completed using, global similar complaint review tool, which reviewed the infection and did not identify any emerging trends or similar complaints that require escalation.Based on a thorough review of the reported complaint, boston scientific has assigned an investigation conclusion code of no problem detected.This supplemental report is being filed to correct the d9: device avail for eval; d9: device return date; g2: report source; h2: follow-up type; h3: device eval by manufacturer; and h11: additional mfr narrative.
|